Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of anthrax.

John G Bartlett1, Thomas V Inglesby, Luciana Borio

  • 1Johns Hopkins University Center for Civilian Biodefense Strategies, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0003, USA. jb@jhmi.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|September 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-use artificial intelligence and biology: upstream risk-benefit reviews.

Frontiers in microbiology·2026
Same author

AI and the Future of Medical Countermeasures to Protect Against Biological Threats.

Open forum infectious diseases·2026
Same author

Biological data governance in an age of AI.

Science (New York, N.Y.)·2026
Same author

Dual-use capabilities of concern of biological AI models.

PLoS computational biology·2025
Same author

Immunomodulator Stockpiling as a Means of Broad Defense From Biological Threats.

Critical care explorations·2025
Same author

Confronting risks of mirror life.

Science (New York, N.Y.)·2024
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

The 2001 anthrax attacks highlighted bioterrorism risks, leading to significant public health and healthcare system changes. This article offers clinical guidance on anthrax diagnosis and management.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Bioterrorism Preparedness

Background:

  • The 2001 anthrax attacks in the US involved 18 confirmed and 4 suspected cases, resulting in 5 deaths.
  • These events underscored the threat of bioterrorism and the need for public health preparedness.
  • Widespread use of prophylactic antibiotics highlighted the potential impact on healthcare systems.

Purpose of the Study:

  • To provide clinicians with clinically relevant information on anthrax.
  • To guide the diagnosis and management of anthrax cases.
  • To inform healthcare professionals about the implications of bioterrorism events.

Main Methods:

  • Review of the 2001 anthrax outbreak in the United States.
  • Analysis of the clinical and public health response.

Related Experiment Videos

  • Synthesis of information for clinical decision-making.

    • Main Results:

    • The anthrax attacks led to significant healthcare system adjustments, including revised pneumonia guidelines.
    • There was an increased focus on identifying microbial causes of disease.
    • Substantial funding was allocated to bioterrorism research and regional disaster planning.

    Conclusions:

    • Clinicians require updated information for diagnosing and managing anthrax.
    • Bioterrorism events necessitate robust public health infrastructure and rapid response capabilities.
    • Preparedness for biological threats is crucial for national security and public health.